NextCure, Inc.
NextCure, Inc.（NXTC）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
nxtc · 股价预测 · 13 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 13 位华尔街分析师
Buy
13 位分析师
共识
评级分布
12 个月目标价
High
$15.00
Consensus
$15.00
+437.6% upside
Low
$15.00
Median: $15 · Last Close: $2.79
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $2.79 | ↑ 0.00% |
1-day model range: $2.72–$2.86. Peak: $2.86 (+0.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · NXTC · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-11-07 | Ladenburg Thalmann | Upgrade ↑ | Neutral→Buy |
| 2025-07-15 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-07-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-17 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-02 | Needham | Maintains | Buy→Buy |
| 2024-06-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-31 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on NextCure, Inc. (NXTC) stock. Of the recent 45 rating actions, 3 were upgrades and 4 were downgrades. 13 analysts currently cover NXTC.
分析师推荐趋势
NXTC analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$3M
↓ 68.0% YoY
Revenue Next Year
$7M
↑ 112.1% YoY
EPS This Year
$-7.33
EPS Next Year
$-8.35
↑ 13.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast NXTC EPS of $-7.33 for the current fiscal year, based on estimates from 2 analysts. The NXTC revenue forecast is $3M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
NXTC 股价预测由两类独立数据源支撑：来自 13 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。NXTC 的共识目标价为 $15.00（+437.6% 上行空间），分析师共识为 Buy。
NXTC 的短期预测（明日）为 $2.79（+0.00%）。
NextCure, Inc. 在 NASDAQ 上市，代码 NXTC。NXTC 在 2027 年的整体展望偏积极，在覆盖分析师中约 85% 对应 Buy 共识。
常见问题
NXTC 预测 · 8 个问题根据 13 位华尔街分析师，NXTC 的 12 个月平均目标价为 $15.00，最高 $15.00、最低 $15.00。若有图表，中位目标价可在上方查看。相对当前价 $2.79，隐含约 +437.6% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.